The Perils of Re-importation:
A Hard Look at Buying Drugs from Canada and Beyond

April 15, 2005

Speaker Biographies

John E. Calfee is a resident scholar at AEI. From 1980 to 1986, he served in the Bureau of Economics at the Federal Trade Commission. Mr. Calfee has taught marketing and consumer behavior in the business schools of the University of Maryland-College Park and Boston University, and was a visiting senior fellow at the Brookings Institution. Mr. Calfee's research has focused on regulation, especially FDA regulation; health care; advertising and information; tort liability; and related areas. He is the author of Prices, Markets, and the Pharmaceutical Revolution (AEI Press, 2000) and Fear of Persuasion: A New Perspective on Advertising and Regulation (distributed by AEI Press, 1997).

Scott Gottlieb, M.D. is a former senior policy adviser to the Commissioner of the Food and Drug Administration (FDA) and to the Administrator of the Centers for Medicare and Medicaid Services (CMS) at the Department of Health and Human Services. At AEI, Dr. Gottlieb researches FDA and CMS regulatory policies, the development of new medical technology, and political and clinical trends in medicine. Dr. Gottlieb is also the author of the new Forbes/Gottlieb Medical Technology Report, an investment newsletter.

John R. Graham is a senior fellow at the Pacific Research Institute and adjunct scholar at the Fraser Institute.  He is the Fraser Institute's former Director, Health and Pharmaceutical Policy.  He received his BA (Honours) in Economics and Commerce from the Royal Military College in Kingston, Ontario, and his MBA from the London Business School of the University of London in London, England.  He has worked as a management consultant and investment banker in Canada and Europe, and served as an infantry officer in the Canadian Army in bases across Canada, as well as in Germany and Cyprus. Works published by the Fraser Institute include a series of papers on the issue of drug re-importation, price differences for prescription drugs between Canada and the U.S., The Fantasy of Reference Pricing, and The Promise of Choice in BC's Pharmacare. He has written for many periodicals, including the Wall Street Journal.